Today before the opening bell, One World Holdings’ subsidiary announced that it will conduct a live stockholders conference call next week on Wednesday, July 1 at 11:30 AM ET.

The primary speakers for this call will be Joanne Melton, One World Holdings CEO; and Stacey McBride-Irby, creator of the Prettie Girls! doll line. The call will also include Trent T. Daniel, Founder of The One World Doll Project, who will be moderating the call.

Because a large number of investors are expected to dial-in, the call will be listen-only. Those who wish to join should dial in at 712-432-0075 pin 278621# no later than 11:28 AM ET on Wednesday, July 1. The call will last no longer than 45 minutes and a recording will be posted to the company website after the call.

For more information on The One World Doll Project subsidiary, visit www.oneworlddolls.com

Let us hear your thoughts: One World Holdings Message Board

Pulse Beverage Corp. is an emerging beverage company that provides consumers with high-quality, healthy alternatives to traditional refreshment options. Since launching its first product, Natural Cabana® Lemonade, in 2012, the company has rapidly expanded its product line to include its flagship PULSE® brand of nutritional beverages, limeade and coconut water. Moving forward, Pulse will look to continue to develop its network of retail outlets, supermarkets and convenience stores in order to become a market leader in the nutritional and functional beverage categories.

In recent years, the functional beverage market in the United States has recorded steady growth, providing Pulse with a significant opportunity to continue expanding its market share in the years to come. According to a report by Statista, retail sales of functional beverages in the U.S. accounted for approximately $16 billion in 2010, and that figure is expected to grow by more than 16 percent by the end of this year. For Pulse, this consumer interest could translate into big returns.

In the first quarter of 2015, the company’s net sales rose by nearly 25 percent, as compared to the same period in 2014. These results were driven by vast expansion to Pulse’s retail distribution network, which now includes some of the world’s biggest retail chains. In particular, the company secured manager approval status with Walmart for its Natural Cabana Lemonade, with an active presence in more than 300 stores to date, as well as listings in 50 Wegmans mega-stores and nearly 500 7-Eleven stores throughout Canada.

“We achieved significant operational progress during the first quarter of 2015,” Bob Yates, chief executive officer of Pulse, stated in a news release. “We have spent 3.5 years in establishing our comprehensive nationwide and international distribution system. We believe this… will lead to a breakout year in 2015.”

Since launching its first product, Pulse has secured more than 20,000 listings for its lemonades and limeades, in addition to more than 5,000 listings for its coconut waters. This month, the company plans to expand upon this progress by introducing its proven lemonade product to the Mexico market, establishing another channel for retail growth in the future.

For prospective shareholders, the rapid expansion of Pulse’s distribution network, the company’s improved financial results and the growing demand of the functional beverage market combine to make Pulse an intriguing investment opportunity in the current market.

For more information, visit www.pulsebeverage.com

Discovery Ventures, Inc. (OTCQX: DTVMF) is an exploration and development stage mining company focused on the WillaMax gold project in southeast British Columbia, Canada. The Willa property is highly developed, with current measured and indicated resources of over 758,000 metric tons grading 6.67 grams of gold per unit. The Max project, which is located approximately 135 kilometers away from the Willa project, features the necessary infrastructure to effectively process the company’s mined resources, providing Discovery with financially-viable means of production moving forward.

Earlier this month, the company announced the results from the recently completed test work program on the Willa Mine. According to the news release, the test, which was conducted by MetSolve Labs, found the metallurgical recoveries from the site’s intermediate grade mineral samples to be greater than indicated by historical records. In the weeks to come, the company will look to build on these strong results as testing on the site’s high grade and sub-grade samples begins.

“We are encouraged by these results,” Akash Patel, president and chief executive officer of Discovery, stated in a news release. “These findings signal a positive outlook for our company’s WillaMax project’s production potential.”

The Willa property has been explored sporadically since 1893. In 2003, a mineral resource calculation was completed on the property based on historical drilling results. Two years later, a preliminary mine design and schedule was developed, but the prevailing metal prices didn’t yield a sufficient return to make production a feasible option. However, an increase in gold prices of approximately 280 percent in the last decade has effectively limited this concern, making the property a potentially lucrative opportunity for Discovery in the future.

In recent weeks, Discovery took a major step toward production by entering into a definitive agreement with investor Dan Omeniuk for up to $7 million in convertible credit. With the proceeds from these credit facilities, the company will look to rapidly advance.

“We are very excited to have Dan Omeniuk join the Discovery team,” continued Patel. “Dan brings a wealth of knowledge and entrepreneurship success and we are confident in his ability to spearhead and advance the WillaMax gold project.”

For more information, visit www.discoveryventuresinc.com

ImmunoCellular Therapeutics, Ltd. is a clinical stage biotechnology company developing immune-based therapies for the treatment of brain and other cancers. The company’s leading product candidate, ICT-107, is a vaccine that targets antigens associated with glioblastoma multiforme (GBM), the most common and lethal form of brain cancer. In recent weeks, ImmunoCellular has made progress toward the initiation of phase III clinical trials for the drug candidate, announcing an agreement with Caladrius Biosciences, Inc. for manufacturing services, including processing, packaging, labelling, quality control testing, release, shipping and storage. Building on this progress, patient enrollment for the trial is expected to begin by the early fourth quarter of this year.

When completed, ICT-107 will address a critically underserved market within the medical industry. According to a report by the American Cancer Society, an estimated 10,000 new patients are diagnosed with GBM in the United States each year. Despite advances in surgery, radiation and chemotherapy, recurrence is a near certainty and the median survival time for newly diagnosed GBM patients in only 14.6 months. In ImmunoCellular’s phase II trials for ICT-107, results suggested potential for greatly increased chances of long-term survival when treated with the company’s novel vaccine.

“We believe that we are on track to initiate the ICT-107 phase III trial in the late third quarter or fourth quarter of this year, following completion of the special protocol assessment process with the FDA and finalization of agreements with cancer cooperative groups and our contract research organization, which will manage the trial,” Andrew Gengos, chief executive officer of ImmunoCellular, stated in a news release. “We believe there is significant value in ImmunoCellular, given the breadth of our platforms and our preclinical and clinical assets, led by ICT-107.”

The company’s product pipeline also includes a dendritic cell-based vaccine that targets CD133, an antigen commonly associated with cancer stem cells. This candidate, known as ICT-121, is nearing the start of phase I clinical trials, with patient enrollment actively underway.

Moving forward, ImmunoCellular is in position to realize its corporate goal of becoming an industry-leading commercial-stage cancer immunotherapy company. Its pipeline of commercially attractive assets could provide the company with the opportunity to achieve sustainable returns while effectively transforming the treatment of cancer.

For more information, visit www.imuc.com

Breitling Energy is a growing energy company engaged in the exploration and development of high probability onshore oil and gas properties. The company’s current portfolio of projects includes leaseholds in the Permian Basin of Texas and the Mississippi oil window of southern Kansas and northern Oklahoma, as well as non-operating investments in Texas, North Dakota, Oklahoma and Mississippi. Leveraging a dual-focused growth strategy, Breitling is expanding its impact on the industry through a combination of active drilling efforts and a growing network of non-operating and royalty interests. This approach allows Breitling to promote sustained growth while diversifying its mineral interest portfolio, effectively limiting operational risk on a well-by-well basis.

In recent weeks, Breitling has achieved major milestones through both portions of its growth strategy. First, the company announced that a new well at its non-operated working interest in Sterling County, Texas, reached total depth and initiated completion operations. Then, Breitling announced the start of fracking operations at its leasehold in the Permian Basin. Despite slumping oil prices, which appear to be slowly recovering following the dramatic decrease during the first quarter of this year, the company’s management is confident that it can realize sustainable returns through these efforts to increase production.

“It’s not so much about price for us as it is optimization,” Chris Faulkner, chairman and chief executive officer of Breitling, stated in a news release. “Our lease in the Permian Basin allows us to be efficient, and we will continue developing the field without debt, which gives us the added confidence to move forward with the company plan we outlined in our first year.”

The company’s Permian Basin leasehold could provide it with a formidable platform to realize substantial growth in the coming years. According to a report by the Railroad Commission of Texas, the region has been a hotbed for the oil and gas industry in recent years. From 2005 to 2012, oil production increased by over 23 percent, climbing to approximately 312 million barrels in the final year of the period.

Moving forward, Breitling appears to be in a strong position to work toward its primary goal of increasing shareholder value through a combination of exploration, drilling and proven engineering extraction practices. For prospective shareholders, the company’s recent progress and the ongoing recovery of global crude oil prices combine to make Breitling an intriguing investment opportunity.

For more information, visit www.breitlingenergy.com

Cibolan Gold is an aggressive junior mining exploration and development company actively pursuing the reopening of its Independence gold and silver mining project in the Battle Mountain Mining District of Nevada. The company’s project, which is located adjacent to the multi-billion dollar Phoenix gold mine of the Newmont Mining Corporation (NEM), contains approximately one million ounces of gold and four million ounces of silver in the measured, indicated and inferred categories, providing Cibolan with a significant opportunity to realize strong returns moving forward.

In April, Cibolan released the results of a preliminary review of the production potential of its Independence project. According to the study, the project has the potential to provide four to five million tons containing more than 200,000 ounces of gold in a financially-viable manner. In particular, the evaluation highlighted three high-grade target areas that could allow the company to expand upon the availability of gold in the near surface mineralized material. As a result, Cibolan plans to focus on the rapid expansion of these new zones in the coming months.

“This is great news for shareholders as we now have a more clear understanding of how the mineralization is controlled by the various faults existing on the property,” Daniel J. Forbush, president and chief executive officer of Cibolan, stated in a news release. “I feel that this development makes Cibolan a ‘must watch’ company for gold focused investors.”

The Independence mine has been in production intermittently since 1938. Historically, the plot has produced approximately 11,000 ounces of gold, as well as about 750,000 ounces of silver. With its technical review of the project now complete, Cibolan moves one step closer to building upon these production statistics. In April, the company announced an agreement with Envirotech Drilling LLC to begin drilling operations in the project’s most promising sites.

For prospective investors, Cibolan’s recent progress toward production makes it an interesting opportunity in the months to come. Look for the company to continue to make strides toward achieving sustainable returns from its Independence project moving forward.

For more information, visit www.nevada-goldmine.com

Aethlon Medical, Inc. (OTCQB: AEMD) creates affinity biofiltration devices to treat life-threatening diseases. The company’s leading therapeutic candidate, the Aethlon Hemopurifier®, is a broad-spectrum therapeutic strategy developed to address drug resistant viral pathogens. To date, the device, which was recently named among ‘The 11 Most Remarkable Advances in Healthcare’ by Time Magazine, has been successfully administered to individuals infected with Ebola virus, hepatitis C and the human immunodeficiency virus (HIV), demonstrating the immense potential for the company’s novel treatment device moving forward.

In addition to validating the treatment of some of the world’s deadliest pathogens, Aethlon is also investigating the use of its Hemopurifier therapy to capture tumor-derived exosomes, which have been shown to promote cancer progression. When complete, this application will address a substantial demand within the cancer treatment market. In April, the company took a significant step toward the eventual commercialization of its proprietary therapeutic candidate by entering into a clinical trial agreement with the University of California, Irvine to establish baseline exosome levels and monitor their associations with various types of cancers. The results of this study will help direct future clinical investigations.

The company’s current product pipeline is built upon its revolutionary Aethlon ADAPT™ system, which is an adaptive dialysis-like affinity platform technology that provides the foundation for a new class of therapeutics that target the selective clearance of harmful agents from the circulatory system. In addition to the Hemopurifier, Aethlon is currently utilizing this system to develop HER2osome™ to target HER2+ breast cancer and a novel medical device to reduce the incidence of sepsis in combat-injured soldiers, which is sponsored by the Defense Advanced Research Projects Agency (DARPA).

Exosome Sciences, Inc., Aethlon’s majority-owned subsidiary, is supporting this product development through the creation of its groundbreaking diagnostic tool, ELLSA™. This device provides greater exosome detection sensitivity than any other product currently on the marketplace. With ELLSA, Aethlon gains enhanced ability to identify and quantify the underlying presence of exosomes in a wide variety of relevant treatment applications.

As Aethlon continues to develop its unique pipeline of therapeutic solutions, the potential for market growth upon commercialization is effectively limitless. With a potential uplisting to the NASDAQ Capital Markets currently pending approval, it is an exciting time for shareholders of this company.

For more information, visit www.aethlonmedical.com

Uranium Energy is a U.S.-based uranium mining and exploration company operating its fully licensed Hobson Processing Plant as the core of all its South Texas projects, including the Palangana in-situ recovery (ISR) mine, the permitted Goliad ISR project, and the development-stage Burke Hollow ISR project. In addition, Uranium Energy controls a pipeline of advanced-stage projects in Arizona, Colorado and Paraguay. By utilizing the Hobson facility, Uranium Energy has eliminated the need to construct a new onsite processing plant for each project.

Billions of dollars are invested in nuclear projects around the world, and while many uranium plays like Cameco Corp. (NYSE:CCJ) maintain chief projects abroad, Uranium Energy is among several other U.S.-focused companies including Uranium Resources, Inc. (NASDAQ:URRE) and Energy Metals Corp. (NYSE:EMC).

Uranium Energy also controls one of the nation’s largest databases of historic uranium exploration and development, which the company uses to acquire and advance exploration of merit throughout the southwestern U.S., a region that has historically been the most concentrated area for uranium mining in the states. With the use of these historical exploration databases, the company identifies acquisition targets that were previously the subject of significant exploration and development by senior energy companies.

Last month Uranium Energy reported the $3.08 million sale of the majority of its uranium inventory at a sale price of $38.50 per pound, 8.5 percent higher than the spot price. As the uranium industry continues its recovery from the 2011 Fukushima Daiichi nuclear disaster and falling uranium prices in 2014, long-term forecasts call for $49 a pound; and Uranium Energy appears to be positioned to capitalize on anticipated market price recovery. Since the company’s production is unhedged and therefore separated from fixed-price contracts, it has wiggle room to wait for a spot price recovery as it ramps up production at Palangana.

For more information visit www.uraniumenergy.com

Definitive Rest Mattress Company is reshaping its business operations in an effort to increase shareholder returns moving forward. In recent months, the company has officially disbanded its previous mattress operations in favor of a new direction focused on metals sales and computer numerical control (CNC) manufacturing. DRMC’s January acquisition of NU Metals Technology, a high grade metals and tooling solutions provider for the aerospace industry, was the first step toward this business transformation.

“We have a clear objective that is driven by technology, beginning with our acquisition of NU Metals Technology,” Juan Carlos Murga, chief executive officer of DRMC, stated in a news release. “[W]e look to the future with long-term growth in all areas of the company by bringing value to shareholders.”

In a recent press release, the company highlighted its early performance results in the aerospace, defense and commercial component manufacturing sectors.

“Recent orders from Asia and domestic companies for stainless and aluminum have set the tone for NU Metals Technology by securing orders until the end of 2015,” continued Murga. “[O]ur future is solid moving forward with new business partners, new company direction and a new mindset; our shareholders will be happy to see DRMC sales activity on the next quarterly report.”

In addition to pushing toward the completion of development on its new corporate website in order to better showcase its new line of products, DRMC is on pace to meet its revenue projections for the third quarter of 2015, according to the company’s management team. In the weeks to come, the company will look to build on this progress and complete its metamorphosis through the announcement of a new corporate name that better reflects its new business operations.

According a report by IBISWorld, the machine shop services industry, including commercial aerospace and transportation manufacturing markets, have experienced robust growth since 2010, climbing to $47 billion in 2015. In the next five years, continued growth is forecast as a result of heightened demand across a collection of manufacturing industries, providing DRMC with ample opportunity to improve financial results.

For prospective investors, DRMC’s recent shift into metal sales and CNC manufacturing could provide an opportunity for sustainable returns in the months to come. The company’s strong revenue projections for the second half of 2015 provide a positive outlook for continued market growth moving forward.

“We are very excited with the company’s rebirth into a vibrant new enterprise within the metals industry and machine tool industry that stretches across many lucrative sectors in manufacturing,” concluded Mulga. “We will leave the old operations behind and look forward to better growth potential and shareholder value with our new direction into these two sectors in industry and technology.”

For more information, visit www.numetalstech.com

According to a report from MarketsandMarkets out in late 2014, the global security screening technology market is on track to hit upwards of $9.1 billion by 2020, growing at a CAGR of roughly 9.4 percent, as point of entry demand and the need to security screen at locations like airports, border checkpoints, railways, schools, sports stadiums, high-profile corporate sites, or government and private facilities like correctional institutions, continues to grow. Security threats ranging from the recent biker shootout in Waco, Texas, to drug trafficking on the southern border with Mexico, as well as the continued rise around the world from terrorism, have created an environment where the need for ubiquitous weapon detection screening systems is paramount. This is particularly true when such screening systems, in combination with other security measures, can provide defensive perimeter solutions that stop bad guys carrying threat objects such as knives, guns, and razor blades in their tracks, identifying and documenting the threat before any lives are lost.

Premier global provider of market intelligence and advisory services, International Data Corporation, foresees a similar degree of growth for the global security and vulnerability management (SVM) sector, with a 10.2% CAGR projection through 2018, citing a marked 9.7 percent increase from the roughly $4 billion in revenues generated during 2013, to roughly $4.4 billion last year. One of the more attractive players in this market is the firmly established and highly competent security services firm, View Systems (OTC: VSYM), which also develops both the proprietary hardware and software needed to realize their growing portfolio of threat detection and ISR (intelligence, surveillance and reconnaissance) products, including their flagship walk-through CWD (concealed weapons detection) system, the ViewScan.

ViewScan is a robust and highly advanced gateway, full-body scanning platform that pairs up a high-fidelity, completely passive sensor array, with the PC-based software needed to execute extremely accurate threat object detection, actively discovering and alerting personnel to the presence of weapons like knives and guns, while eliminating false positives and filtering out every day personal items like coins, keys, jewelry, or belt buckles. Moreover, the system is completely safe for medical devices like pacemakers and yet the standard version of the unit weighs just 56 lbs (75 lbs total shipping weight), can be easily moved around for deployment at different entryways and even comes with an optional 4-hour battery backup capability that allows the system to be used almost anywhere. ViewScan can be set up in fifteen minutes using only a Phillips screwdriver, works with off the shelf computing systems and the company even makes a companion detector, the fully automatic and adjustable LAW Handheld Metal Detector, to help further ensure rapid screening throughput, minimal need for pat down inspections, and maximum operator safety.

A simplified yet powerful GUI (graphical user interface) for the company’s proprietary ViewScan software bundle allows even inexperienced operators to harness the rapid throughput capabilities this system can deliver. The ViewScan platform is designed to rapidly capture images (including those from optional additional cameras) and other important data, as well as print out such evidence, and the system seamlessly integrates with VSYM’s biometric fingerprint reader-enabled Positive ID Verification System as well. ViewScan presents users with an unmistakably simplified visual display indication of not only positive threat detection, but where on a person’s body the threat is located. The ViewScan even comes in a variety of formats, including a foldable Ultralite version so compact it can be checked on an airline flight, weighs only 23 lbs (45 lbs total shipping weight), and comes packed in its own SKB Corp. brand, high-quality molded polymer travel case.

The company’s Positive ID Verification System was specifically engineered to offer correctional, facilities, courthouses, office complexes, school sites and other secured locations the ability to quickly and accurately screen visitors and employees, and comes complete with an ID scanner and self-adhesive visitor badge with photo printer, in addition to the biometric fingerprint reader. Both of these systems are designed to document and record data, archiving images and logging processing activity information into a database that can be printed out as a daily or monthly report, complete with timestamps and relevant data on the individual, like name and ID or other identifying number(s). Similarly, the company’s first response remote video transmission system, Visual First Responder (VFR), a wearable video and infrared system designed to be carried on a belt or helmet and document or relay important video data, is capture-minded and allows users to fully document use, either for training purposes or subsequent legal action. Created to specifically address Law Enforcement, SWAT team, Fire Rescue team or HAZMAT team requirements, the rugged and compact body-worn camera with 5-mile transmitter based VFR platform, is ideal for handling a broad spectrum of roles. The VFR system feeds clear, steady, real-time and optionally encrypted video back to a viewing console, and can easily be mounted on even K-9 units.

The company recently announced that they are seeing continued traction and momentum build up in California, Michigan and Texas for their products, capitalizing on a sophisticated representative and dealer network that has been able to keep successfully landing new clients and installation contracts. ViewScan in particular is finding fast favor among clientele like event security organizers, educational institutions and law enforcement facilities, given the affordability and ease of implementation the system provides. The aggregate security industry is one of the fastest growing segments of the global economy over the last decade and with revenues currently in the neighborhood of $100 billion plus annually, there is considerable room for VSYM to grow on the strength of their revolutionary weapon detection systems and other ISR/SVM offerings.

Learn more about the company by visiting www.viewsystems.com

Let us hear your thoughts: View Systems, Inc. Message Board